New paths for energy with hydrogen
At the ESI Platform at the Paul Scherrer Institute PSI, researchers are seeking solutions for Switzerland's energy future and improving the efficiency of modern forms of renewable energy. With a mini gas turbine, they now have closed another energy cycle.
EU grants 14 million to Swiss Researchers
A team with three researchers from the ETH Domain has been awarded a prestigious EU grant. Today, they received the contract signed by the EU confirming the extraordinary 14 million euros funding. With it, they will investigate quantum effects which could become the backbone of future electronics.
On the go at 200 kilometres per hour
Fabia Gozzo is no woman for the comfort zone. First she made a beamline at the Swiss Light Source SLS of the Paul Scherrer Institute PSI into one of the world's leading facilities. Today she is making her knowledge available to industry with her spin-off.
Making the impossible possible
Use of multiferroic materials promises more energy-efficient computers because in these, an electric field would suffice to achieve magnetic data storage. Researchers at PSI have now made such a material suitable for computer operating temperatures.
Why the Little Ice Age ended in the middle of the 19th century
In the first half of the 19th century, a series of large volcanic eruptions in the tropics led to a temporary global cooling of Earth's climate. That Alpine glaciers grew and subsequently receded again during the final phase of the so-called Little Ice Age was due to a natural process. This has now been proven by PSI researchers on the basis of ice cores.
30 years Paul Scherrer Institute PSI
Ceremony with invited guests from politics, business and sciencePSI held its 30 Years of PSI ceremony. The PSI showed guests what it has achieved over the past three decades, with results that could be of benefit to everyone in Switzerland.
Licence agreement with Swiss pharma firm for development of a cancer drug
A radioactive agent, developed at the Paul Scherrer Institute PSI to fight an especially malignant form of thyroid cancer, has the potential to become a blockbuster drug. Due to its structure, it might also be able to dock onto cells of other tumours and destroy them with its radiation. The Lausanne-based biopharmaceutical company Debiopharm wants to further develop the PSI agent to the point where it is approved as a drug. Debiopharm and PSI have now created the contractual basis for this.
This time, it's all bio: SwissFEL makes protein structures visible
For the development of new medicinal agents, accurate knowledge of proteins is crucial. In a pilot experiment, researchers have now, for the first time, used the X-ray free-electron laser SwissFEL of PSI for the examination of protein crystals.
From researcher to entrepreneur
Towards new shores: At the Paul Scherrer Institute PSI, enterprising researchers are venturing into the unknown. They're leaving their safe haven to become successful entrepreneurs. The journey from PSI to one's own spin-off takes courage. To keep the voyage from getting too stormy, PSI supports its business founders as they navigate through rough waters, and maintains these connections over many years.
The Swiss Federal Interim Storage Facility
In medicine, industry, and research as well as in power generation radioactive waste occurs. In Switzerland, there are currently two central interim storage facilities. The Federal interim storage facility for waste stemming from medicine, industry and research is located on the grounds of PSI.
A biotechnological revolution
Gebhard Schertler is head of the research division Biology and Chemistry at the Paul Scherrer Institute PSI and professor for Structural Biology at ETH Zurich. In this interview he talks about biological research at PSI and the future of drug development.
How do dye-sensitised solar cells work, and what's behind the brilliant new mobile phone displays? The ultrashort X-ray pulses at SwissFEL reveal the chemical reactions that take place inside these devices and could help to make them even more efficient and cost-effective.
Material from PSI helps to check inconsistencies in the Big Bang theory
Shortly after the Big Bang, radioactive Beryllium-7 atoms were formed, which today, throughout the universe, they have long since decayed. A sample of beryllium-7 artificially produced at PSI has now helped researchers to better understand the first minutes of the universe.
On the path to new high-performance transistors
The electronics industry expects a novel high-performance transistor made of gallium nitride to offer considerable advantages over present-day high-frequency transistors. Yet many fundamental properties of the material remain unknown. Now, for the first time, researchers at the Paul Scherrer Institute PSI have observed electrons while they were flowing in this promising transistor. For that they used one of the world's best sources of soft X-rays at PSI's Swiss Light Source SLS.
Cleaner emissions thanks to sponge-like structure
PSI researchers have developed a new catalytic converter for cleaning emissions from natural gas engines. It is very active even at low temperatures and remains that way over a long period of time. This allows natural gas to be burned in a cleaner, more climate-friendly way. Thus natural gas and biogas become more attractive as substitutes for petroleum products – for example, as fuel for cars.
Movie directors with extra roles
Data storage devices based on novel materials are expected to make it possible to record information in a smaller space, at higher speed, and with greater energy efficiency than ever before. Movies shot with the X-ray laser show what happens inside potential new storage media, as well as how the processes by which the material switches between two states can be optimised.
Biological light sensor filmed in action
Using X-ray laser technology, a team led by researchers of the Paul Scherrer Institute PSI has recorded one of the fastest processes in biology. In doing so, they produced a molecular movie that reveals how the light sensor retinal is activated in a protein molecule. Such reactions occur in numerous organisms. The movie shows for the first time how a protein efficiently controls the reaction of the embedded light sensor.
Hollywood in the Würenlingen woods
With the X-ray laser SwissFEL, researchers at PSI want to produce movies of biomolecules in action. This can reveal how our eyes function or how new drugs work.
Imaging the inside of injection needles with neutrons
Researchers from the Paul Scherrer Institute PSI, the University of Basel and Roche have used neutron imaging to investigate why cool storage is crucial for syringes pre-filled with a liquid medication.